Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Calder Biosciences's investors include SOSV, SOSV SF & NY (Fka IndieBio), National Institute on Aging, National Institute of Allergy and Infectious Diseases, Genesis Consortium.
Calder Biosciences is headquartered in New York, United States.
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Calder Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calder Biosciences — Funding & Investors." VCBacked, May 20, 2025, https://www.vcbacked.co/company/calder-biosciences. Accessed August 14, 2026.
VCBacked. (2025). Calder Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/calder-biosciences
{{cite web |title=Calder Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/calder-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated